One well down, plenty to go for Elixir

|

Published 27-MAY-2021 11:42 A.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

Elixir Energy Limited’s (ASX:EXR) Cracker-1S well has reached a target depth of 563 metres, intersecting Triassic sequences.

Management was hoping that Permian sequences would be intersected, but to put this in perspective this well is just one of many to be drilled in an extensive exploration program at the Nomgon IX Coal Bed Methane (CBM) Production Sharing Contract (PSC) in Mongolia.

The Cracker-1S exploration strat-hole, located in the far North-West of the PSC was the first ever well in the local sub-basin and was drilled on seismic acquired in 2020, reaching a target depth of 563 metres.

This was a step-out well with far more variables and uncertainties than have been the case with the company’s numerous successful wells, and the most significant takeaway is that it will still provide valuable information in terms of the group’s future exploration strategy.

The well has been remediated and the Erdene Drilling LLC rig is now moving to drill the West Yangir1 core-hole.

This core-hole should provide valuable information as it is intended to provide data for a first stage production test well planned for later in the year as the company moves to expand its exploration and appraisal program to include multi-stage and multi-location production testing.

In further promising news, COVID-19 restrictions in Mongolia have eased, and the second drilling company contracted by Elixir has now moved a rig into the PSC area.

The new rig will initially drill a shallow exploratory well, Manlai 1S, in a new sub-basin in the far North-West of the PSC, 130 kilometres from the Nomgon Discovery (see below).

The well is targeting shallower Permian sediments, and this will be followed up by a deeper well in the same sub-basin upon confirmation of encountering the Permian stratigraphy.

Seismic programme to identify targets for expanded field program

Elixir’s 2021 2D seismic program has been proceeding swiftly and it has now acquired 140 kilometres of new seismic.

This is being processed rapidly in order to feed the multi-rig drilling program.

Elixir is currently finalising locations for new seismic lines to be shot as part of the company’s expanded field program.

As flagged in the company’s last quarterly report, a SODAR (Sonic Detection and Ranging) unit has now arrived in Mongolia and is being deployed into the area of current field operations to measure renewable energy resources.

Discussing the much improved operating environment in terms of accelerating expansion, while reinforcing Elixir’s low-cost “rinse and repeat” strategy, managing director Neil Young said, “We are pleased to finally welcome our second Mongolian drilling company – Top Diamond Drilling – into the field in yet another of the many sub-basins in the PSC.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X